BR0013230A - 4,4-diaril-(ciclo-hexanos) 1,4-substituìdos - Google Patents

4,4-diaril-(ciclo-hexanos) 1,4-substituìdos

Info

Publication number
BR0013230A
BR0013230A BR0013230-6A BR0013230A BR0013230A BR 0013230 A BR0013230 A BR 0013230A BR 0013230 A BR0013230 A BR 0013230A BR 0013230 A BR0013230 A BR 0013230A
Authority
BR
Brazil
Prior art keywords
diaryl
cyclohexanes
substituted
hexans
analogous
Prior art date
Application number
BR0013230-6A
Other languages
English (en)
Inventor
Siegfried B Christensen Iv
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR0013230A publication Critical patent/BR0013230A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/20Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

"4,4-DIARIL-(CICLO-HEXANOS) 1,4-SUBSTITUìDOS". Esta invenção refere-se a compostos da Fórmula (I) , onde Z é uma amina, álcool ou seu derivado, e a cetona análoga a eles.
BR0013230-6A 1999-08-10 2000-08-10 4,4-diaril-(ciclo-hexanos) 1,4-substituìdos BR0013230A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14803499P 1999-08-10 1999-08-10
PCT/US2000/021867 WO2001010385A2 (en) 1999-08-10 2000-08-10 1,4-substituted 4,4-diaryl cyclohexanes

Publications (1)

Publication Number Publication Date
BR0013230A true BR0013230A (pt) 2002-04-23

Family

ID=22523946

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013230-6A BR0013230A (pt) 1999-08-10 2000-08-10 4,4-diaril-(ciclo-hexanos) 1,4-substituìdos

Country Status (19)

Country Link
US (1) US6518306B1 (pt)
EP (1) EP1202955A4 (pt)
JP (1) JP2003522129A (pt)
KR (1) KR20020022102A (pt)
CN (1) CN1368952A (pt)
AU (1) AU6763900A (pt)
BR (1) BR0013230A (pt)
CA (1) CA2378990A1 (pt)
CO (1) CO5190716A1 (pt)
CZ (1) CZ2002460A3 (pt)
HU (1) HUP0202936A3 (pt)
IL (1) IL148032A0 (pt)
MX (1) MXPA02001471A (pt)
NO (1) NO20020597L (pt)
NZ (1) NZ516620A (pt)
PL (1) PL353360A1 (pt)
TR (1) TR200200347T2 (pt)
WO (1) WO2001010385A2 (pt)
ZA (1) ZA200201036B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
US20040001895A1 (en) * 2002-06-17 2004-01-01 Pfizer Inc. Combination treatment for depression and anxiety
UA83266C2 (en) * 2003-12-08 2008-06-25 Уайет Oxazole derivatives of tetracyclines
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
CA2561047C (en) * 2004-04-08 2013-07-16 Wyeth Method for preparing 3-cyclopentyloxy-4-methoxybenzaldehyde
US7825265B2 (en) 2004-05-04 2010-11-02 Acadia Pharmaceuticals Inc. Compounds with activity at estrogen receptors
MXPA06012705A (es) * 2004-05-04 2007-03-26 Acadia Pharm Inc Compuestos con actividad en receptor de estrogeno.
KR100694873B1 (ko) * 2005-05-26 2007-03-13 주식회사 대인정밀 정수기
TW200716536A (en) 2005-06-09 2007-05-01 Chugai Pharmaceutical Co Ltd Vitamin D compounds
JP2011500563A (ja) * 2007-10-10 2011-01-06 メルク・シャープ・エンド・ドーム・コーポレイション ジフェニル置換されたシクロアルカン

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019750A1 (en) * 1992-04-02 1993-10-14 Smithkline Beecham Corporation Compounds useful for treating allergic or inflammatory diseases
DE69328778T2 (de) * 1992-04-02 2000-11-23 Smithkline Beecham Corp., Philadelphia Verbindungen für die behandlung von entzündlichen erkrankungen und zur hemmung der produktion von tumornekrosefaktor
JPH07278038A (ja) * 1994-04-01 1995-10-24 Sumitomo Chem Co Ltd 多官能ビニルエーテル化合物
BR9510257A (pt) * 1994-12-23 1997-11-04 Smithkline Beecham Corp Monômeros ciclohexan-1-óis 4,4-(di-substituidos) e compostos relacionados
PL321001A1 (en) * 1994-12-23 1997-11-24 Smithkline Beecham Corp Monomers of 4,4-disubstituted cyclohexan-1-one and compounds showing affinity to them
AR004471A1 (es) * 1995-05-31 1998-12-16 Smithkline Beecham Corp Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen
UY25338A1 (es) * 1998-01-07 2001-08-27 Smithkline Beecham Corp Método para tratar copd

Also Published As

Publication number Publication date
EP1202955A2 (en) 2002-05-08
JP2003522129A (ja) 2003-07-22
HUP0202936A3 (en) 2003-11-28
ZA200201036B (en) 2003-04-30
WO2001010385A2 (en) 2001-02-15
CA2378990A1 (en) 2001-02-15
NO20020597D0 (no) 2002-02-06
CZ2002460A3 (cs) 2002-06-12
CO5190716A1 (es) 2002-08-29
US6518306B1 (en) 2003-02-11
AU6763900A (en) 2001-03-05
NZ516620A (en) 2004-03-26
TR200200347T2 (tr) 2002-06-21
CN1368952A (zh) 2002-09-11
PL353360A1 (en) 2003-11-17
EP1202955A4 (en) 2004-02-11
WO2001010385A3 (en) 2001-08-16
MXPA02001471A (es) 2002-07-02
IL148032A0 (en) 2002-09-12
KR20020022102A (ko) 2002-03-23
NO20020597L (no) 2002-04-03
HUP0202936A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
BR0014470A (pt) Inibidores de fab i
TR200101071T2 (tr) Mantar ilacı olarak kullanılan 2-piridilmetilamin türevleri.
FI950309A (fi) Proliiniamidijohdannaisia
DE60212867D1 (de) Thiazolylsubstituierte aminopyrimidine als pflanzenschutzmittel
BR9813848A (pt) Composto heterocìclico fundido substituìdo, uso do mesmo, e, composição farmacêutica.
ATE409189T1 (de) Farnesyl transferase-hemmende 6- heterocyclylmethyl-chinolin und chinazol-derivate
BR0013230A (pt) 4,4-diaril-(ciclo-hexanos) 1,4-substituìdos
BR9706792A (pt) Derivado de tiazol
DE60118225D1 (de) Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
DE60117847D1 (de) Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
ATE209627T1 (de) Schlüsselzwischenprodukte zur herstellung von simvastatin
DE69908954D1 (de) Antibakterielle zusammensetzungen
AU2001269540A1 (en) Serotonin reuptake inhibitors
BR0015318A (pt) Compostos de o-éter de oxima, e, fungicida para uso agrìcola e hortìcola
DK1209151T3 (da) 4-substituerede piperidinderivativer
NZ336091A (en) Aqueous disinfecting cleaning composition
DE60228429D1 (de) Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält
DE60119383D1 (de) Farnesyltransferasehemmende 4-heterocyclylchinolin- und chinazolinderivate
SE9704770D0 (sv) New use
DE60139080D1 (de) Farnesyltransferase hemmende benzoheterocyclische derivate
RS50790B (sr) Korišćenje derivata piridoindolona za spravljanje lekova
FR2707496B1 (fr) Compositions pharmaceutiques antiradicalaires et/ou antilipoperoxydantes et/ou hépatotropes.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.